RU2020102910A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2020102910A3 RU2020102910A3 RU2020102910A RU2020102910A RU2020102910A3 RU 2020102910 A3 RU2020102910 A3 RU 2020102910A3 RU 2020102910 A RU2020102910 A RU 2020102910A RU 2020102910 A RU2020102910 A RU 2020102910A RU 2020102910 A3 RU2020102910 A3 RU 2020102910A3
- Authority
- RU
- Russia
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01035—Hyaluronoglucosaminidase (3.2.1.35), i.e. hyaluronidase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762531215P | 2017-07-11 | 2017-07-11 | |
US62/531,215 | 2017-07-11 | ||
PCT/US2018/041661 WO2019014360A1 (en) | 2017-07-11 | 2018-07-11 | POLYPEPTIDES BINDING COMPONENT C5 OR SERUM ALBUMIN COMPONENT AND FUSION PROTEINS THEREOF |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2022112308A Division RU2022112308A (ru) | 2017-07-11 | 2018-07-11 | Полипептиды, которые связываются с компонентом комплемента c5 или сывороточным альбумином, и их белки слияния |
Publications (3)
Publication Number | Publication Date |
---|---|
RU2020102910A RU2020102910A (ru) | 2021-08-11 |
RU2020102910A3 true RU2020102910A3 (ru) | 2021-12-02 |
RU2794359C2 RU2794359C2 (ru) | 2023-04-17 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
US20230235033A1 (en) | 2023-07-27 |
MX2024005945A (es) | 2024-06-11 |
CA3067247A1 (en) | 2019-01-17 |
BR112019028269A2 (pt) | 2020-07-14 |
JP2020532285A (ja) | 2020-11-12 |
CO2020000369A2 (es) | 2020-01-31 |
CN111201246B (zh) | 2023-10-27 |
AU2018301412A1 (en) | 2020-01-30 |
CN111201246A (zh) | 2020-05-26 |
US11498960B2 (en) | 2022-11-15 |
JP2023120208A (ja) | 2023-08-29 |
IL271920B1 (en) | 2023-11-01 |
WO2019014360A8 (en) | 2019-02-21 |
EP3625265A1 (en) | 2020-03-25 |
IL307197A (en) | 2023-11-01 |
KR20200026264A (ko) | 2020-03-10 |
RU2020102910A (ru) | 2021-08-11 |
IL271920A (en) | 2020-02-27 |
CN117327187A (zh) | 2024-01-02 |
MX2024005946A (es) | 2024-06-11 |
WO2019014360A1 (en) | 2019-01-17 |
US20200399351A1 (en) | 2020-12-24 |
CN117327188A (zh) | 2024-01-02 |
IL271920B2 (en) | 2024-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR122021024397A2 (ru) | ||
BR122021023687A2 (ru) | ||
BR122021000189A2 (ru) | ||
BR112019008823A2 (ru) | ||
BR112020006084A8 (ru) | ||
BR112019025295B1 (pt) | Compostos, composição, uso de um composto da fórmula i, método para combater fungos fitopatogênicos e semente revestida | |
BR122021014832A2 (ru) | ||
BR202018014992U2 (ru) | ||
BR122022003520A2 (ru) | ||
BR112020008820A2 (ru) | ||
BR202017025154U2 (ru) | ||
BR102017023327A2 (ru) | ||
BR202017021228U2 (ru) | ||
BR202017020981U2 (ru) | ||
BR202017017068U2 (ru) | ||
BR202017016984U2 (ru) | ||
BR202017016924U2 (ru) | ||
BR102017015495A2 (ru) | ||
BR102017015250A2 (ru) | ||
BR102017014430A2 (ru) | ||
BR202017012548U2 (ru) | ||
BR202017011220U2 (ru) | ||
CN303991096S (ru) | ||
CN303996310S (ru) | ||
CN303990988S (ru) |